By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > NSAID > Celecoxib

Celecoxib

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|586 words

Celecoxib Drug Profile

What is Celecoxib?

Celecoxib is a prescription nonsteroidal anti-inflammatory drug (NSAID) that belongs to a specific subclass called COX-2 selective inhibitors. It is primarily used to treat pain, inflammation, and stiffness associated with arthritis and other inflammatory conditions. Unlike traditional NSAIDs, celecoxib was designed to reduce gastrointestinal side effects while maintaining anti-inflammatory effectiveness.

Uses

Celecoxib is FDA-approved for several conditions:

  • Osteoarthritis: Reduces joint pain and stiffness in the most common form of arthritis
  • Rheumatoid arthritis: Helps manage inflammation and pain in this autoimmune condition
  • Ankylosing spondylitis: Treats inflammation of the spine and large joints
  • Acute pain: Provides short-term relief for various types of pain conditions
  • Primary dysmenorrhea: Alleviates menstrual pain and cramping

How it works

Celecoxib works by selectively blocking the COX-2 enzyme, which is responsible for producing prostaglandins that cause inflammation, pain, and fever. Unlike traditional NSAIDs that block both COX-1 and COX-2 enzymes, celecoxib primarily targets COX-2, theoretically sparing the COX-1 enzyme that helps protect the stomach lining. This selective action was designed to reduce the risk of stomach ulcers and bleeding commonly associated with other NSAIDs.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Stomach pain or upset
  • Diarrhea
  • Headache
  • Dizziness
  • Cold or flu-like symptoms
  • Swelling in hands or feet
  • Gas or bloating
  • Nausea

Serious side effects requiring immediate medical attention:

  • Heart attack or stroke symptoms
  • Severe allergic reactions including skin rash or difficulty breathing
  • Signs of liver problems such as yellowing of skin or eyes
  • Kidney problems including decreased urination or swelling
  • Severe stomach bleeding or ulcers

Warnings and precautions

  • Cardiovascular risk: Celecoxib may increase the risk of heart attack and stroke, especially with long-term use or in people with existing heart disease
  • Gastrointestinal bleeding: Despite being COX-2 selective, celecoxib can still cause serious stomach and intestinal bleeding, particularly in elderly patients
  • Pregnancy considerations: Should be avoided during the third trimester as it may cause harm to the unborn baby and complications during delivery
  • Kidney and liver function: Regular monitoring may be needed in patients with kidney or liver disease, as celecoxib can worsen these conditions
  • Allergic reactions: Patients allergic to sulfonamides, aspirin, or other NSAIDs should use with extreme caution

Interactions

  • Warfarin and blood thinners: Increases bleeding risk when combined with anticoagulant medications
  • ACE inhibitors and ARBs: May reduce the effectiveness of these blood pressure medications and increase kidney problems
  • Lithium: Celecoxib can increase lithium levels in the blood, potentially causing toxicity
  • Methotrexate: May increase methotrexate toxicity by reducing its elimination from the body
  • Fluconazole: This antifungal medication can significantly increase celecoxib levels
  • Aspirin: Combining with low-dose aspirin may increase gastrointestinal bleeding risk
  • Diuretics: May reduce the effectiveness of water pills and increase kidney problems
  • Other NSAIDs: Should not be used together due to increased risk of side effects

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary by condition:

  • Osteoarthritis: 200 mg once daily or 100 mg twice daily
  • Rheumatoid arthritis: 100-200 mg twice daily
  • Ankylosing spondylitis: 200 mg once daily or 100 mg twice daily
  • Acute pain and menstrual cramps: 400 mg initially, followed by 200 mg as needed

The lowest effective dose should be used for the shortest duration necessary. Maximum daily dose should not exceed 400 mg. Dosage adjustments may be necessary for patients with liver impairment. Always consult your healthcare provider to determine the appropriate dosage for your specific condition and medical history.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Celecoxib." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/celecoxib/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Trump’s Perfect Cognitive Test Score: What Montreal Cognitive Assessment Really Measures

President Trump's perfect 30/30 score on cognitive testing prompts medical experts to…

Breakthrough Drug Targeting ‘Undruggable’ KRAS Mutation Nearly Doubles Pancreatic Cancer Survival

New targeted therapy daraxonrasib successfully inhibits KRAS mutations in pancreatic cancer, nearly…

Large Brazilian Study Links Table Salt Habits to Cognitive Decline in 8,300 Older Adults

A comprehensive study of 8,300 older Brazilian adults found that men are…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Indomethacin

By
Prof. Giorgi Pkhakadze
02/06/2026

Etoricoxib

By
Prof. Giorgi Pkhakadze
02/06/2026

Piroxicam

By
Prof. Giorgi Pkhakadze
02/06/2026

Naproxen

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up